logo

For the Inventor, By the Inventor

Evry, France

Université D'evry-Val-D'essonne

USPTO Granted Patents = 30

% Expired Patents = 3.3


Forward Citations = 18

Loading Chart...
Loading Chart...

70 inventors (with patents filed for the assignee):

goldMedal Federico Mingozzi (5 out of 15 patents)

silverMedal Isabelle Richard (4 out of 11 patents)

bronzeMedal Giuseppe Ronzitti (3 out of 5 patents)

4.  Daniel Scherman (3 out of 38 patents)

5.  Jean-Michel Rozet (3 out of 7 patents)

6.  Antoine Kichler (3 out of 8 patents)

7.  Isabelle Perrault (3 out of 7 patents)

8.  Josseline Kaplan (3 out of 7 patents)

9.  Xavier Gerard (3 out of 6 patents)

10.  M Arnold Munnich (3 out of 5 patents)

11.  William Lostal (3 out of 3 patents)

12.  Giuseppe Ronzitti (3 out of 3 patents)

13.  Federico Mingozzi (3 out of 4 patents)

14.  Ana Maria Buj Bello (2 out of 11 patents)

15.  Pasqualina Colella (2 out of 4 patents)


Core Competencies:
Endothelial Cells
Gene Therapy
Thrombus Segmentation
Recombinant Vectors
Composite Beads
AAV Vectors
Biochips
Nucleotide Disorders
Glycogen Storage Disease
Polynucleotides
Protein Prenylation
Eukaryotic Cells

30 patents:

1. 12723263 - VECTORS ENCODING A GLUCOSE-6-PHOSPHATASE (G6PASE-A) FOR GENE THERAPY (2026-09-01),
2. 12723237 - Method for obtaining endothelial cells from pluripotent stem cells (2026-09-01),
3. 12705741 - Automatic method for segmentation of a thrombus and a lesion in a three-dimensional brain image (2026-08-11),
4. 12668812 - RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME (2026-06-30),
5. 12662512 - CHIMERIC POLYPEPTIDES AND USES THEREOF (2026-06-23),
6. 12649673 - Synthesis of composite beads coated with layered manganese oxide and use of such beads to remove toxic elements contained in fluids (2026-06-09),
7. 12637668 - MINI-GDE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE III (2026-05-26),
8. 12582723 - POLYNUCLEOTIDES ENCODING A HUMAN FKRP PROTEIN (2026-03-24),
9. 12466864 - PRODUCTION OF LARGE-SIZED QUASIDYSTROPHINS USING OVERLAPPING AAV VECTORS (2025-11-11),
10. 12305187 - Acid-alpha glucosidase variants and uses thereof (2025-05-20),
11. 12195368 - Method for decontaminating heavy metals in an aqueous solution (2025-01-14),
12. 12171843 - Hybrid regulatory elements (2024-12-24),
13. 12037362 - Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism (2024-07-16),
14. 11993781 - Stable pseudotyped lentiviral particles and uses thereof (2024-05-28),
15. 11754561 - Functionalized biochips for SPR-MS coupling (2023-09-12),
Company Overview
Université D'Evry-Val-D'Essonne is a prominent institution of higher education located in Evry, France. It specializes in a diverse range of fields, including computer science, biotechnology, and social sciences. The university is dedicated to fostering innovation and research, collaborating with various industries to advance knowledge and technology. Its strategic location in the Île-de-France region enhances its role in regional development and partnerships, contributing to both academic and practical advancements in various disciplines.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

30 Patents

#3 in Evry

#727 in France

#21,912 in the World

Evry, FR
Evry, France

Université D'evry-Val-D'essonne

Forward Citations = 18

70 inventors:

goldMedal Federico Mingozzi (5 out of 15 patents)

silverMedal Isabelle Richard (4 out of 11 patents)

bronzeMedal Giuseppe Ronzitti (3 out of 5 patents)

4.  Daniel Scherman (3 out of 38 patents)

5.  Jean-Michel Rozet (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Université D'evry-Val-D'essonne. Retrieved from https://idiyas.com/company/universite-d-evry-val-d-essonne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…